Climb Bio board sees director resignation, adds Breanna O'Reilly

Climb Bio, Inc. disclosed board changes in an 8-K reporting an event date of June 29, 2026, with the filing itself signed and dated July 1, 2026. On June 29, 2026, Andrew Levin notified the board of directors of Climb Bio, Inc. of his resignation as a member of the Board, effective immediately.¹

Also on June 29, 2026, upon the recommendation of the nominating and corporate governance committee of the Board, Breanna O'Reilly, Ph.D., was elected as a member of the Board, effective immediately.¹ Dr. O'Reilly was elected to serve with a term expiring at the Company's 2027 annual meeting of stockholders and thereafter until her successor has been duly appointed and qualified or until her earlier death, resignation or removal.¹

As part of her compensation, Dr. O'Reilly will receive a grant on June 29, 2026 of an option to purchase 70,284 shares of the Company's common stock at an exercise price equal to $13.36 per share, the closing price of the Company's common stock on the Grant Date, which option will vest in equal monthly installments from June 29, 2026 until the third anniversary of the Vesting Commencement Date, subject to her continued service.¹ She will also be entitled to receive annual cash retainers in the amount of $40,000 for her service as a director and annual equity grants in accordance with the Company's non-employee director compensation policy.¹

The filing states there are no arrangements or understandings between Dr. O'Reilly and any other persons pursuant to which she was elected as a director, she has no family relationships with any of the Company's directors or executive officers, and there are no related-party transactions and no proposed transactions between the Company and Dr. O'Reilly that would require disclosure under Item 404(a) of Regulation S-K.¹ Dr. O'Reilly has entered into an indemnification agreement with the Company, the form of which was filed as Exhibit 10.8 to the Company's Registration Statement on Form S-1 filed with the SEC on August 2, 2021.¹